The global western blotting market accounted for US$638.82 Mn in 2018 and is expected to grow at a CAGR of 5% over the forecast period 2021-2027 to grow to US$992.55 Mn by 2027. Western blot is always preferred over enzymes. Linked immunosorbent assay (ELISA) test for HIV detection because it more accurately detects HIV antibodies in the patient’s blood. However, medical professionals prescribe ELISA on the first attempt to test for HIV. However, western blots are more helpful in checking for HIV infection in the patient’s body. This test tool is much more complex than ELISA, but provides more accurate and effective results in detecting the HIV virus. According to LymeDisease.org, 52% of chronic diseases have a negative ELISA test but a positive Western blot.
(Get 15% Discount on Buying this Report)
A full report of Western Blotting Market available at: https://www.orionmarketreports.com/western-blotting-market/2418/
Global Western Blotting Market Segmentations
By Product
• Consumables
• Instruments
By Application
• Biochemical & Biomedical Research
• Disease Diagnostics
• Agriculture
• Other Applications
By End User
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Other End Users
Reasons to Buying From us –
• We cover more than 15 major industries, further segmented into more than 90 sectors.
• More than 120 countries are for analysis.
• Over 100+ paid data sources mined for investigation.
• Our expert research analysts answer all your questions before and after purchasing your report.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
